[ Price : $8.95]
FDA classifies as Class 1 a Zimmer Biomet recall of its EBI Osteogen Implantable Bone Growth Stimulator, SpF Plus-Mini (60 μA...[ Price : $8.95]
FDA approves Bayer and Loxo Oncologys Vitrakvi (larotrectinib) for treating adult and pediatric cancers in patients who have a spe...[ Price : $8.95]
Former FDA associate commissioner Peter Lurie says FDA may have to lower its medical device approval standards if it wants to be t...[ Price : $8.95]
FDA says it is lowering the minimum measles antibody potency specification for immune globulin products.[ Price : $8.95]
A Goldwater Institute investigative report faults FDA caution in approving new drugs, saying it stifles innovation and leads to un...[ Price : $8.95]
FDA declines a BioElectronics 510(k) submission for its ActiPatch, seeking expanded over-the-counter indications for treating musc...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include The Delano Co. and Mylan Pharmaceuticals.[ Price : $8.95]
Six drug company stakeholders ask FDA for changes to an agency draft guidance on post-approval changes to drug substances.